<html>
<head>PUBMED IDs for NYX</head>
<body bgcolor='#C5F0F2'><h1>NYX</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8580831/'>DCC (deleted in colorectal cancer) inactivation in hematological malignancies.</a> June 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8810315/'>Identification of a novel guanine nucleotide exchange factor for the Rho GTPase.</a> October 11  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8832876/'>An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.</a> October 18  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8955068/'>Biochemical characterization of a novel KRAS insertion mutation from a human leukemia.</a> December 20  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9148952/'>Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells.</a> May 16  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9419974/'>Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.</a> January 7  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9650617/'>A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy.</a> July 3  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9811680/'>Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells.</a> November 13  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10363984/'>Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy.</a> June 11  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10416603/'>Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas.</a> July 23  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10436844/'>Pancreaticobiliary cancer: the future aspects of medical oncology.</a> August 7  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10608346/'>Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effects.</a> December 23  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11127580/'>Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status.</a> January 11  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10706117/'>ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.</a> March 8  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10728673/'>In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.</a> March 23  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10825139/'>Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53.</a> May 29  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10932224/'>a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.</a> August 10  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11005557/'>A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).</a> September 27  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11017144/'>Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).</a> October 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11062472/'>The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein.</a> November 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11062471/'>Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness.</a> November 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11103798/'>Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.</a> December 5  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11156251/'>Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.</a> January 13  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11287579/'>Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.</a> April 5  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11313813/'>Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis.</a> April 21  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11313805/'>Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.</a> April 21  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11369253/'>Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors.</a> May 23  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11408949/'>Case populations must match the respective disease model: Genotype diversity causes linkage disequilibrium mapping failure in monogenic disorders.</a> June 16  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11420638/'>Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity.</a> June 23  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11426653/'>ONYX-015 selectivity and the p14ARF pathway.</a> June 28  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11507034/'>p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.</a> August 17  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11509942/'>Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region.</a> August 18  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11581222/'>Slow and fast rod ERG pathways in patients with X-linked complete stationary night blindness carrying mutations in the NYX gene.</a> October 3  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11830531/'>Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.</a> February 7  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11890870/'>Head and neck cancer: gene therapy approaches. Part II: genes delivered.</a> March 14  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11892945/'>ONYX-015. Onyx Pharmaceuticals.</a> March 15  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11892944/'>Overview: synthetic gene delivery: another quest for the Holy Grail?</a> March 15  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11896105/'>Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer.</a> March 16  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11895000/'>Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.</a> March 16  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12050209/'>ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines.</a> June 7  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12086848/'>Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents.</a> June 28  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12187427/'>Infantile and childhood retinal blindness: a molecular perspective (The Franceschetti Lecture).</a> August 21  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12187394/'>Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil.</a> August 21  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12187393/'>Body weight changes and the A-6G polymorphism of the angiotensinogen gene.</a> August 21  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12187392/'>Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement.</a> August 21  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12397430/'>Phenotypic expression of the complete type of X-linked congenital stationary night blindness in patients with different mutations in the NYX gene.</a> October 25  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12438574/'>Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes.</a> November 20  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12522442/'>Adenoviral vectors: systemic delivery and tumor targeting.</a> January 11  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12528315/'>Selectively replicating adenoviruses for cancer therapy: an update on clinical development.</a> January 17  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12538449/'>Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants.</a> January 23  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12552565/'>Mutations in the CACNA1F and NYX genes in British CSNBX families.</a> January 29  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12576437/'>Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.</a> February 11  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12576418/'>A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.</a> February 11  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12610835/'>[Establishment of the concept of new clinical entities--complete and incomplete form of congenital stationary night blindness].</a> March 4  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12719704/'>Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients.</a> April 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12719702/'>Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.</a> April 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12727116/'>Multigene expression from a replicating adenovirus using native viral promoters.</a> May 3  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12810646/'>A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.</a> June 18  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12888833/'>Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts.</a> July 31  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14508094/'>Cancer-specific viruses and the development of ONYX-015.</a> September 26  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14507859/'>NYX (nyctalopin on chromosome X), the gene mutated in congenital stationary night blindness, encodes a cell surface protein.</a> September 26  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14557644/'>Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.</a> October 15  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14557490/'>ONYX-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells.</a> October 15  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14583489/'>A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38.</a> October 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14674605/'>Replicating adenoviruses in cancer therapy.</a> December 17  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14682374/'>Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.</a> December 20  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14682372/'>Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.</a> December 20  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14728805/'>An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy.</a> January 20  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15144568/'>Combination of Targeting Gene-ViroTherapy with 5-FU enhances antitumor efficacy in malignant colorectal carcinoma.</a> May 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15331616/'>Primate Retinal Signaling Pathways: Suppressing ON-Pathway Activity in Monkey With Glutamate Analogues Mimics Human CSNB1-NYX Genetic Night Blindness.</a> August 28  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15389517/'>Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma.</a> September 25  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15455796/'>A comparison of ERG abnormalities in XLRS and XLCSNB.</a> October 1  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15455736/'>Polymorphisms in the vitamin D receptor gene are associated with periodontal disease.</a> October 1  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15514685/'>Tumor-specific intravenous gene delivery using oncolytic adenoviruses.</a> October 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15551339/'>Congenital stationary night blindness: report of an autosomal recessive family and linkage analysis.</a> November 20  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15583843/'>Multifocal oscillatory potentials in CSNB1 and CSNB2 type congenital stationary night blindness.</a> December 8  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15603511/'>The tumor suppressor gene TP53: implications for cancer management and therapy.</a> December 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15607965/'>Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.</a> December 21  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15647767/'>Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.</a> January 14  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/19202637/'>Clinical trials: the sensitizing side of ONYX-015.</a> February 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15761389/'>Novel mutations in CACNA1F and NYX in Dutch families with X-linked congenital stationary night blindness.</a> March 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15762988/'>Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells.</a> March 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15762987/'>Gene expression signature of estrogen receptor alpha status in breast cancer.</a> March 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15762985/'>Evolutionary sequence analysis of complete eukaryote genomes.</a> March 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15762933/'>Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.</a> March 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15762932/'>Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients.</a> March 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15771958/'>Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.</a> March 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15818382/'>The potential of oncolytic virus therapy for pancreatic cancer.</a> April 9  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15905181/'>Species specific membrane anchoring of nyctalopin, a small leucine-rich repeat protein.</a> May 21  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16000066/'>Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.</a> July 8  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16101516/'>The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally?</a> August 17  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16247442/'>p53 promotes adenoviral replication and increases late viral gene expression.</a> October 26  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16261423/'>Isolation and characterization of the leucine-rich proteoglycan nyctalopin gene (cNyx) from chick.</a> November 2  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16553780/'>Localization of nyctalopin in the mammalian retina.</a> March 24  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16670814/'>CSNB1 in Chinese families associated with novel mutations in NYX.</a> May 4  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16971969/'>Adenoviral gene therapy in head and neck cancer.</a> September 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17004930/'>Nyctalopin is essential for synaptic transmission in the cone dominated zebrafish retina.</a> September 29  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17008933/'>Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis.</a> September 30  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17018633/'>Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.</a> October 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17102812/'>Targeting gene-virotherapy of cancer and its prosperity.</a> November 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17167712/'>Reovirus - possible therapy of cancer.</a> December 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17167711/'>[Association between tumor necrosis factor-alpha promoter polymorphisms and type 2 diabetes and obesity in Chilean elderly women].</a> December 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17392683/'>Mutations in NYX of individuals with high myopia, but without night blindness.</a> March 30  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17518613/'>Modification of the Rb-binding domain of replication-competent adenoviral vector enhances cytotoxicity against human esophageal cancers via NF-kappaB activity.</a> May 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17577631/'>Synergistic induction of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying TRAIL.</a> June 20  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17704755/'>A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients.</a> August 21  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17881478/'>Nyctalopin expression in retinal bipolar cells restores visual function in a mouse model of complete X-linked congenital stationary night blindness.</a> September 21  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17975564/'>The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411(NTR).</a> November 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18473990/'>Molecular targeting in pancreatic cancer.</a> May 14  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18583996/'>ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice.</a> June 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18583992/'>Lost in translation--prognostic signatures for breast cancer.</a> June 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18617546/'>A common NYX mutation in Flemish patients with X linked CSNB.</a> July 12  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18683102/'>Virus combinations and chemotherapy for the treatment of human cancers.</a> August 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18771358/'>Human telomerase reverse transcriptase promoter-driven oncolytic adenovirus with E1B-19 kDa and E1B-55 kDa gene deletions.</a> September 6  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19129452/'>E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus.</a> March 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19407849/'>RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses.</a> January 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19407846/'>Prevalence of myocilin gene mutations in a novel UK cohort of POAG patients.</a> April 19  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19458647/'>In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer.</a> June 30  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19481338/'>E1B-55kD-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancer.</a> October 15  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19878917/'>Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans.</a> December 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19896113/'>TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness.</a> December 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20165905/'>Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7/IL-24.</a> September 23  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20596091/'>A fully replication-competent adenovirus vector with enhanced oncolytic properties.</a> January 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21361787/'>Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.</a> January 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21975464/'>The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models.</a> February 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22325361/'>Whole-exome sequencing identifies mutations in GPR179 leading to autosomal-recessive complete congenital stationary night blindness.</a> June 20  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22735794/'>Mutation screening of TRPM1, GRM6, NYX and CACNA1F genes in patients with congenital stationary night blindness.</a> November 7  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23246293/'>Whole-exome sequencing identifies LRIT3 mutations as a cause of autosomal-recessive complete congenital stationary night blindness.</a> March 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23289809/'>Electroretinographic findings in a patient with congenital stationary night blindness due to a novel NYX mutation.</a> March 15  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23406521/'>A novel missense mutation in the NYX gene associated with high myopia.</a> November 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25093639/'>ORCA-010, a novel potency-enhanced oncolytic adenovirus, exerts strong antitumor activity in preclinical models.</a> June 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25364261/'>Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives.</a> November 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25376708/'>Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter.</a> September 25  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25802485/'>NYX mutations in four families with high myopia with or without CSNB1.</a> September 12  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26234941/'>Two Novel NYX Gene Mutations in the Chinese Families with X-linked Congenital Stationary Night Blindness.</a> August 4  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26234940/'>Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.</a> March 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26310623/'>Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness.</a> August 3  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26368928/'>A Naturally Occurring Canine Model of Autosomal Recessive Congenital Stationary Night Blindness.</a> June 1  2015<br></body></html>
